2018
DOI: 10.1016/j.ejmech.2018.04.005
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
38
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 70 publications
(45 citation statements)
references
References 21 publications
0
38
0
1
Order By: Relevance
“…Yu et al 47 synthesised a series of 1,2,3-triazolo-dihydroartemisinincoumarin hybrids and screened their anticancer potentials in two types of cancer cells. These hybrids displayed modest cytotoxicity towards HT-29 and MDA-MB-231 cell lines, particularly under hypoxic condition.…”
Section: Introductionmentioning
confidence: 99%
“…Yu et al 47 synthesised a series of 1,2,3-triazolo-dihydroartemisinincoumarin hybrids and screened their anticancer potentials in two types of cancer cells. These hybrids displayed modest cytotoxicity towards HT-29 and MDA-MB-231 cell lines, particularly under hypoxic condition.…”
Section: Introductionmentioning
confidence: 99%
“…The molecular docking studies revealed that compound 13 bonded through multiple interactions, including hydrogen bonding and hydrophobic interactions against telomerase reverse transcriptase. Yu et al [46] designed and synthesized 34 new dihydroartemisinin-coumarin analogs, and these analogs represented remarkable cytotoxic activities against HT-29 and MDA-MB-231 cell lines, especially under hypoxia condition. The SAR study and docking analysis had shown that carbonic anhydrases IX was the main target of the hybrids.…”
Section: Anticancer Activitymentioning
confidence: 99%
“…14 Additionally, enzyme inhibitory properties of some benzimidazolium salts were reported. [15][16][17][18] In recent years, many research groups focused on the synthesis and anti-cancer properties of hybrid compounds of coumarin with other bio-active heterocyclic moieties such as pyrimidine, 19 chalcone, 20 ÎČcarboline, 21 indole-triazole, 22 artemisinin, 23 thiazole, 24 and isooxazilones. 25 In the meantime, hybrid compounds of benzimidazole and their anticancer properties were reported with various heterocyclic moieties such as triazine, 26 ellipticine, 27 tetrazine, 28 deoxynucleosides, 29 thiazoles, 30 and chrysin.…”
Section: Introductionmentioning
confidence: 99%